메뉴 건너뛰기




Volumn 17, Issue 2, 2008, Pages 165-172

Pegylated interferon α-2a and ribavirin combination therapy in HCV liver transplant recipients. Experience of 7 cases

Author keywords

Antiviral therapy; Liver transplantation; Recurrent hepatitis C

Indexed keywords

CYCLOSPORIN; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEGINTERFERON ALPHA2A; PREDNISONE; RIBAVIRIN; TACROLIMUS; THYROTROPIN;

EID: 46449105469     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (7)

References (37)
  • 1
    • 0036793302 scopus 로고    scopus 로고
    • Natural history of recurrent hepatitis C
    • Berenguer M. Natural history of recurrent hepatitis C. Liver Transpl 2002; 8(10 Suppl): S14-S18.
    • (2002) Liver Transpl , vol.8 , Issue.10 SUPPL.
    • Berenguer, M.1
  • 2
    • 0032924021 scopus 로고    scopus 로고
    • Recurrent and new hepatitis C virus infection after liver transplantation
    • Everhart JE, Wei Y, Eng H, et al. Recurrent and new hepatitis C virus infection after liver transplantation. Hepatology 1999; 29: 1220-1226.
    • (1999) Hepatology , vol.29 , pp. 1220-1226
    • Everhart, J.E.1    Wei, Y.2    Eng, H.3
  • 3
    • 0038798716 scopus 로고    scopus 로고
    • Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients
    • Mohsen AH, Easterbrook PJ, Taylor C, et al. Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut 2003; 52:1035-1040.
    • (2003) Gut , vol.52 , pp. 1035-1040
    • Mohsen, A.H.1    Easterbrook, P.J.2    Taylor, C.3
  • 4
    • 0032899215 scopus 로고    scopus 로고
    • High incidence of allograft cirrhosis in hepatitis C virus genotype lb infection following transplantation: Relationship with rejection episodes
    • Prieto M, Berenguer M, Rayon JM, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype lb infection following transplantation: relationship with rejection episodes. Hepatology 1999; 29: 250-256.
    • (1999) Hepatology , vol.29 , pp. 250-256
    • Prieto, M.1    Berenguer, M.2    Rayon, J.M.3
  • 5
    • 0032573676 scopus 로고    scopus 로고
    • Hepatitis C infection in patients undergoing liver retransplantation
    • Rosen HR, Martin P. Hepatitis C infection in patients undergoing liver retransplantation. Transplantation 1998; 66: 1612-1616.
    • (1998) Transplantation , vol.66 , pp. 1612-1616
    • Rosen, H.R.1    Martin, P.2
  • 7
    • 0035934568 scopus 로고    scopus 로고
    • Peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomized trial
    • Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 2001; 358: 958-965.
    • (2001) Lancet , vol.358 , pp. 958-965
    • Manns, M.P.1    McHutchison, J.G.2    Gordon, S.C.3
  • 8
    • 0037179698 scopus 로고    scopus 로고
    • Peginterferon alpha-2a plus ribavirin for chronic hepatitis C virus infection
    • Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alpha-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347: 975-982.
    • (2002) N Engl J Med , vol.347 , pp. 975-982
    • Fried, M.W.1    Shiffman, M.L.2    Reddy, K.R.3
  • 9
    • 2442683905 scopus 로고    scopus 로고
    • Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotype 2 or 3
    • Zeuzcm S, Hultcrantz R, Bourliere M, et al. Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotype 2 or 3. J Hepatol 2004; 40: 993-999.
    • (2004) J Hepatol , vol.40 , pp. 993-999
    • Zeuzcm, S.1    Hultcrantz, R.2    Bourliere, M.3
  • 10
    • 15644380122 scopus 로고    scopus 로고
    • Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferonalpha therapy
    • Marcellin P, Boyer N, Gervais A, et al. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferonalpha therapy. Ann Intern Med 1997; 127: 875-881.
    • (1997) Ann Intern Med , vol.127 , pp. 875-881
    • Marcellin, P.1    Boyer, N.2    Gervais, A.3
  • 13
    • 33746924102 scopus 로고    scopus 로고
    • Treating hepatitis C infection in liver transplant recipients
    • Terrault N, Berenguer M. Treating hepatitis C infection in liver transplant recipients. Liver Transpl 2006; 12: 1192-1204.
    • (2006) Liver Transpl , vol.12 , pp. 1192-1204
    • Terrault, N.1    Berenguer, M.2
  • 14
    • 2342418781 scopus 로고    scopus 로고
    • Effectiveness of interferon alpha-2b and ribavirin combination therapy in the treatment of naive chronic hepatitis C patients in clinical practice
    • Shehab TM, Fontana RJ, Oberhelman K, Marrero JA, Su GL, Lok AS. Effectiveness of interferon alpha-2b and ribavirin combination therapy in the treatment of naive chronic hepatitis C patients in clinical practice. Clin Gastroenterol Hepatol 2004; 2: 425-431.
    • (2004) Clin Gastroenterol Hepatol , vol.2 , pp. 425-431
    • Shehab, T.M.1    Fontana, R.J.2    Oberhelman, K.3    Marrero, J.A.4    Su, G.L.5    Lok, A.S.6
  • 15
    • 0036207348 scopus 로고    scopus 로고
    • The association between hepatitis C infection and survival after orthotopic liver transplantation
    • Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002; 122: 889-896.
    • (2002) Gastroenterology , vol.122 , pp. 889-896
    • Forman, L.M.1    Lewis, J.D.2    Berlin, J.A.3    Feldman, H.I.4    Lucey, M.R.5
  • 16
    • 0033807694 scopus 로고    scopus 로고
    • Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation
    • Berenguer M, Prieto M, Rayon JM, et al. Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation. Hepatology 2000; 32: 852-858.
    • (2000) Hepatology , vol.32 , pp. 852-858
    • Berenguer, M.1    Prieto, M.2    Rayon, J.M.3
  • 17
    • 33745343818 scopus 로고    scopus 로고
    • Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: A review and quantitative analysis
    • Wang CS, Ko HH, Yoshida EM, Marra CA, Richardson K. Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis. Am J Transplant 2006; 6: 1586-1599.
    • (2006) Am J Transplant , vol.6 , pp. 1586-1599
    • Wang, C.S.1    Ko, H.H.2    Yoshida, E.M.3    Marra, C.A.4    Richardson, K.5
  • 18
    • 1642293907 scopus 로고    scopus 로고
    • Treatment of recurrent hepatitis C after liver transplantation: A pilot study of peginterferon alfa-2b and ribavirin combination
    • Dumortier J, Scoazec JY, Chevallier P, Boillot O. Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination. J Hepatol 2004; 40: 669-674.
    • (2004) J Hepatol , vol.40 , pp. 669-674
    • Dumortier, J.1    Scoazec, J.Y.2    Chevallier, P.3    Boillot, O.4
  • 19
    • 20444377637 scopus 로고    scopus 로고
    • Combined treatment with pegylatcd interferon (alfa-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation
    • Castells L, Vargas V, Allende H, et al. Combined treatment with pegylatcd interferon (alfa-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation. J Hepatol 2005; 43: 53-59.
    • (2005) J Hepatol , vol.43 , pp. 53-59
    • Castells, L.1    Vargas, V.2    Allende, H.3
  • 20
    • 8644285360 scopus 로고    scopus 로고
    • Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy
    • Neff GW, Montalbano M, O'Brien CB, et al. Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy. Transplantation 2004; 78: 1303-1307.
    • (2004) Transplantation , vol.78 , pp. 1303-1307
    • Neff, G.W.1    Montalbano, M.2    O'Brien, C.B.3
  • 21
    • 33747519995 scopus 로고    scopus 로고
    • Treatment of patients with recurrent hepatitis C after liver transplantation with peginterferon alfa-2B plus ribavirin
    • Neumann U, Puhl G, Bahra M, et al. Treatment of patients with recurrent hepatitis C after liver transplantation with peginterferon alfa-2B plus ribavirin. Transplantation 2006; 82: 43-47.
    • (2006) Transplantation , vol.82 , pp. 43-47
    • Neumann, U.1    Puhl, G.2    Bahra, M.3
  • 22
    • 22444439336 scopus 로고    scopus 로고
    • Pegylated-interferon alpha 2b and ribavirin for recurrent hepatitis C after liver transplantation: From a Canadian experience to recommendations for therapy
    • Babatin M, Schindel L, Burak KW. Pegylated-interferon alpha 2b and ribavirin for recurrent hepatitis C after liver transplantation: From a Canadian experience to recommendations for therapy. Can J Gastroenterol 2005; 19: 359-365.
    • (2005) Can J Gastroenterol , vol.19 , pp. 359-365
    • Babatin, M.1    Schindel, L.2    Burak, K.W.3
  • 23
    • 33745997054 scopus 로고    scopus 로고
    • Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C
    • Berenguer M, Palau A, Fernandez A, et al. Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C. Liver Transpl 2006; 12: 1067-1076.
    • (2006) Liver Transpl , vol.12 , pp. 1067-1076
    • Berenguer, M.1    Palau, A.2    Fernandez, A.3
  • 24
    • 33748497126 scopus 로고    scopus 로고
    • Hepatitis C recurrence after liver transplantation: Viral and histologic response to full-dose PEG-interferon and ribavirin
    • Oton E, Barcena R, Moreno-Planas JM, et al. Hepatitis C recurrence after liver transplantation: viral and histologic response to full-dose PEG-interferon and ribavirin. Am J Transplant 2006; 6: 2348-2355.
    • (2006) Am J Transplant , vol.6 , pp. 2348-2355
    • Oton, E.1    Barcena, R.2    Moreno-Planas, J.M.3
  • 25
    • 0037302607 scopus 로고    scopus 로고
    • Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C recurrence
    • Bizollon T, Ahmed SN, Radenne S, et al. Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C recurrence. Gut 2003; 52: 283-287.
    • (2003) Gut , vol.52 , pp. 283-287
    • Bizollon, T.1    Ahmed, S.N.2    Radenne, S.3
  • 26
    • 1242307253 scopus 로고    scopus 로고
    • Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C
    • Abdclmalek MF, Firpi RJ, Soldevila-Pico C, et al. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C. Liver Transpl 2004; 10: 199-207.
    • (2004) Liver Transpl , vol.10 , pp. 199-207
    • Abdclmalek, M.F.1    Firpi, R.J.2    Soldevila-Pico, C.3
  • 27
    • 34247863801 scopus 로고    scopus 로고
    • Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: A randomized controlled study
    • Carrion JA, Navasa M, Garcia-Retortillo M, et al. Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study. Gastroenterology 2007; 132: 1746-1756.
    • (2007) Gastroenterology , vol.132 , pp. 1746-1756
    • Carrion, J.A.1    Navasa, M.2    Garcia-Retortillo, M.3
  • 28
    • 34250866552 scopus 로고    scopus 로고
    • Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence
    • Sharma P, Marrero JA, Fontana RJ, et al. Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence. Liver Transpl 2007;13:1100-1108.
    • (2007) Liver Transpl , vol.13 , pp. 1100-1108
    • Sharma, P.1    Marrero, J.A.2    Fontana, R.J.3
  • 29
    • 22944435223 scopus 로고    scopus 로고
    • Successful treatment of hepatitis C reinfection with interferon-alpha2b and ribavirin after liver transplantation. A long-term follow-up
    • Yedibela S, Schuppan D, Muller V, et al. Successful treatment of hepatitis C reinfection with interferon-alpha2b and ribavirin after liver transplantation. A long-term follow-up. Liver Int 2005; 25: 717-722.
    • (2005) Liver Int , vol.25 , pp. 717-722
    • Yedibela, S.1    Schuppan, D.2    Muller, V.3
  • 30
    • 3442898180 scopus 로고    scopus 로고
    • Prevention and treatment of hepatitis C virus recurrence after liver transplantation
    • Garcia-Retortillo M, Forns X. Prevention and treatment of hepatitis C virus recurrence after liver transplantation. J Hcpatol 2004; 41: 2-10.
    • (2004) J Hcpatol , vol.41 , pp. 2-10
    • Garcia-Retortillo, M.1    Forns, X.2
  • 31
    • 1942450774 scopus 로고    scopus 로고
    • Impact of pcgylated interferon alfa-2b and ribavirin on liver fibrosis for recurrent hepatitis C in liver transplantation - a single center experience [Abstr.]
    • Mukherjec S, Gilroy RK, Rogge J, et al. Impact of pcgylated interferon alfa-2b and ribavirin on liver fibrosis for recurrent hepatitis C in liver transplantation - a single center experience [Abstr.]. Hepatology 2003; 38: 227A.
    • (2003) Hepatology , vol.38
    • Mukherjec, S.1    Gilroy, R.K.2    Rogge, J.3
  • 32
    • 10744233319 scopus 로고    scopus 로고
    • Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylatcd interferon alpha2b and ribavirin: An open-label scries
    • Rodriguez-Luna H, Khatib A, Sharma P, et al. Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylatcd interferon alpha2b and ribavirin: an open-label scries. Transplantation 2004; 77: 190-194.
    • (2004) Transplantation , vol.77 , pp. 190-194
    • Rodriguez-Luna, H.1    Khatib, A.2    Sharma, P.3
  • 33
    • 34250794991 scopus 로고    scopus 로고
    • Ribavirin with cither standard or pcgylated interferon to treat recurrent hepatitis C after liver transplantation
    • Cicinnati VR, Iacob S, Klein CG, ct al. Ribavirin with cither standard or pcgylated interferon to treat recurrent hepatitis C after liver transplantation. Aliment Pharmacol Ther. 2007; 26: 291-303.
    • (2007) Aliment Pharmacol Ther , vol.26 , pp. 291-303
    • Cicinnati, V.R.1    Iacob, S.2    Klein, C.G.3    ct al4
  • 34
    • 0242624204 scopus 로고    scopus 로고
    • Pegylatcd interferon alfa-2b plus ribavirin in patients with hepatitis C reinfection after OLT [Abstr.]
    • Bahra M, Neumann UP, Berg T, et al. Pegylatcd interferon alfa-2b plus ribavirin in patients with hepatitis C reinfection after OLT [Abstr.]. Am J Transplant 2003; 3: 432.
    • (2003) Am J Transplant , vol.3 , pp. 432
    • Bahra, M.1    Neumann, U.P.2    Berg, T.3
  • 35
    • 19944430229 scopus 로고    scopus 로고
    • Pegasys Transplant Study Group. Peginterferon alfa-2a for hepatitis C after liver transplantation: Two randomized, controlled trials
    • Chalasani N, Manzarbeitia C, Fcrenci P, et al. Pegasys Transplant Study Group. Peginterferon alfa-2a for hepatitis C after liver transplantation: two randomized, controlled trials. Hepatology 2005; 41:289-298.
    • (2005) Hepatology , vol.41 , pp. 289-298
    • Chalasani, N.1    Manzarbeitia, C.2    Fcrenci, P.3
  • 36
    • 0028316548 scopus 로고
    • Hepatitis C virus infection is a risk factor for liver failure from vcno-occlusive disease after bone marrow transplantation
    • Frickhofcn N, Wiesncth M, Jainta C, et al. Hepatitis C virus infection is a risk factor for liver failure from vcno-occlusive disease after bone marrow transplantation. Blood 1994; 83: 1998-2004.
    • (1994) Blood , vol.83 , pp. 1998-2004
    • Frickhofcn, N.1    Wiesncth, M.2    Jainta, C.3
  • 37
    • 6444236097 scopus 로고    scopus 로고
    • One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection
    • Firpi R, Abdelmalek MF, Soldevila-Pico C, et al. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection. Liver Transpl 2004; 10: 1240-1247.
    • (2004) Liver Transpl , vol.10 , pp. 1240-1247
    • Firpi, R.1    Abdelmalek, M.F.2    Soldevila-Pico, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.